Whether the use of the synthetic agonist can reverse the tumor suppression effects of the mGluR2/3 antagonist mentioned above is not well established, but it might be possible that the use of the natural ligand of mGluR2/3 and the use of the synthetic agonist can stimulate tumor cell proliferation and tumor growth in vivo. Here, GRM2 is linked to neoplasm.